Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-29

Clinical Trial Update: Online Mindfulness-based Tic Reduction (Phase Two) [NA]

View source ↗

Summary

A Phase Two online mindfulness-based tic reduction trial for Tourette Syndrome and Persistent Tic Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bowdoin College | Conditions: Tourette Syndrome, Persistent Tic Disorder | NA | Status: COMPLETED